Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Alex Ossola

👤 Speaker
9916 total appearances
Voice ID

Voice Profile Active

This person's voice can be automatically recognized across podcast episodes using AI voice matching.

Voice samples: 8
Confidence: High

Appearances Over Time

Podcast Appearances

WSJ What’s News
Why Everyone Is Talking About Peptides

What's more, users are increasingly finding the drugs on the gray market, which presents its own set of risks.

WSJ What’s News
Why Everyone Is Talking About Peptides

I discussed all this with Sarah O'Brien, who covers the business and culture of wellness for the journal.

WSJ What’s News
Why Everyone Is Talking About Peptides

Sarah, I want to start with the kind of like bare bones definition of what a peptide is.

WSJ What’s News
Why Everyone Is Talking About Peptides

Like if I were in high school biology class, what would I learn about what a peptide is?

WSJ What’s News
Why Everyone Is Talking About Peptides

So when someone on social media is talking about all their peptides and their peptide stack, do they mean something different?

WSJ What’s News
Why Everyone Is Talking About Peptides

Right.

WSJ What’s News
Why Everyone Is Talking About Peptides

And just to clarify what unapproved means, there's off-label use for many drugs, and then there's using a straight-up illegal drug, and there's a lot of stuff in between.

WSJ What’s News
Why Everyone Is Talking About Peptides

Where does this fall?

WSJ What’s News
Why Everyone Is Talking About Peptides

Who is primarily buying these drugs and who's selling them?

WSJ What’s News
Why Everyone Is Talking About Peptides

How much does it typically cost to buy these drugs off social media?

WSJ What’s News
Why Everyone Is Talking About Peptides

Coming up, the risks that unapproved peptides bring and where they go from here.

WSJ What’s News
Why Everyone Is Talking About Peptides

That's after the break.

WSJ What’s News
Why Everyone Is Talking About Peptides

I know that you said that the FDA hasn't approved these drugs for some of the things that people are taking them for.

WSJ What’s News
Why Everyone Is Talking About Peptides

But that doesn't mean they don't do that.

WSJ What’s News
Why Everyone Is Talking About Peptides

Do we actually know that any of these peptides as ingredients do some of the things that are promised?

WSJ What’s News
Why Everyone Is Talking About Peptides

Unattended side effects is a pretty big negative consequence of some of this.

WSJ What’s News
Why Everyone Is Talking About Peptides

But are there possible other negative consequences that come with how people are acquiring these drugs?

WSJ What’s News
Why Everyone Is Talking About Peptides

I want to zoom back out now for a minute because...

WSJ What’s News
Why Everyone Is Talking About Peptides

This is a particular moment in the sort of pursuit of beauty, the pursuit of perfection.

WSJ What’s News
Why Everyone Is Talking About Peptides

But I would say pretty confidently that this is not the first, right?